Holocene Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.35M Buy
+133,542
New +$4.63M 0.01% 352

Other funds holding VKTX

Holocene Advisors's VKTX Position: Q3 2026 in Review

Holocene Advisors opened a new position in Viking Therapeutics (VKTX) in Q3 2026: 133,542 shares worth $4.35M. The stake represents 0.01% of the portfolio and ranks #352 among its holdings.

444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.

  • Holocene Advisors held 133,542 shares of Viking Therapeutics worth $4.35M as of Q3 2026.
  • Viking Therapeutics was a new Holocene Advisors position in Q3 2026.
  • Viking Therapeutics made up 0.01% of Holocene Advisors's portfolio in Q3 2026, its #352 holding.
  • 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.

Based on Holocene Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.